Sassa T, Kumada T, Nakano S, Uematsu T
Department of Pharmacology, Gifu University School of Medicine, Japan.
Eur J Gastroenterol Hepatol. 1999 Dec;11(12):1387-92. doi: 10.1097/00042737-199912000-00008.
To evaluate the diagnostic efficacy of simultaneous measurements of high-sensitivity des-gamma-carboxy prothrombin (H-DCP) and Lens culinaris agglutinin A-reactive alpha-fetoprotein (AFP-L3) in small hepatocellular carcinoma (HCC).
Sixty-one patients with small HCCs < or = 2 cm in diameter and 134 controls (chronic hepatitis: 59 cases; cirrhosis: 75 cases) were examined. H-DCP was measured by electrochemiluminescence immunoassay (cut-off 40 mAU/ml (milli-arbitrary units/ml) and AFP-L3% (percentage of AFP-L3/total AFP) by lectin-affinity electrophoresis coupled with the antibody-affinity blotting method (cut-off 10%). Fifty-six patients were histologically diagnosed and the remaining five patients were diagnosed clinically.
Of 61 patients, 27 (44.3%) were positive for H-DCP and 14 (23.0%) were positive for AFP-L3. There was no correlation between H-DCP and AFP-L3%. Nineteen patients (31.1%) had positive H-DCP alone. Six patients (9.8%) had positive AFP-L3 alone, and in eight patients (13.1%) both markers were positive. In combination assay, 33 of 61 patients (54.1%) were positive for either marker; specificity and accuracy were 97.8% and 84.1%, respectively. There was a tendency for the AFP-L3% to be elevated in patients with moderately or poorly differentiated HCC (P= 0.0564) and multiple HCC nodules (P= 0.0316), while the H-DCP showed no elevation related to the tumour type.
The detection rate of small HCC was improved by combination assay with H-DCP and AFP-L3%. Our results indicate that the markers are complementary and useful for the diagnosis and evaluation of small HCC when measured simultaneously.
评估同时检测高灵敏度去γ-羧基凝血酶原(H-DCP)和刀豆凝集素A反应性甲胎蛋白(AFP-L3)对小肝细胞癌(HCC)的诊断效能。
对61例直径≤2 cm的小HCC患者和134例对照者(慢性肝炎:59例;肝硬化:75例)进行检测。采用电化学发光免疫分析法检测H-DCP(临界值为40 mAU/ml(毫任意单位/毫升)),采用凝集素亲和电泳结合抗体亲和印迹法检测AFP-L3%(AFP-L3占总AFP的百分比)(临界值为10%)。56例患者经组织学诊断,其余5例患者经临床诊断。
61例患者中,27例(44.3%)H-DCP阳性,14例(23.0%)AFP-L3阳性。H-DCP与AFP-L3%之间无相关性。19例患者(31.1%)仅H-DCP阳性。6例患者(9.8%)仅AFP-L3阳性,8例患者(13.1%)两种标志物均阳性。联合检测时,61例患者中有33例(54.1%)至少一种标志物阳性;特异性和准确性分别为97.8%和84.1%。中分化或低分化HCC患者(P = 0.0564)和多发HCC结节患者(P = 0.0316)的AFP-L3%有升高趋势,而H-DCP未显示出与肿瘤类型相关的升高。
H-DCP和AFP-L3%联合检测提高了小HCC的检出率。我们的结果表明,这两种标志物具有互补性,同时检测时对小HCC的诊断和评估有用。